tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Compare Ascendis Pharma (ASND) vs. Competitors

Compare
680 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ascendis Pharma
$219.73
$13.43B
-51.18
67.98%
13 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$57.62
$11.07B
21.41
-10.96%
8 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$42.65
$11.43B
17.84
26.29%
4 Buy
5 Hold
1 Sell
Moderate Buy
Madrigal Pharmaceuticals
$478.61
$10.87B
-35.63
36.31%
9 Buy
2 Hold
0 Sell
Strong Buy
United Therapeutics
$482.59
$20.78B
18.15
35.22%
4 Buy
2 Hold
0 Sell
Moderate Buy
BridgeBio Pharma
$75.19
$14.49B
-15.22
90.01%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ASND
Ascendis Pharma
217.38
92.36
73.88%
BMRN
BioMarin Pharmaceutical
57.15
-7.19
-11.18%
EXEL
Exelixis
42.37
8.70
25.84%
MDGL
Madrigal Pharmaceuticals
463.42
133.15
40.32%
UTHR
United Therapeutics
478.93
125.18
35.39%
BBIO
BridgeBio Pharma
63.73
31.03
94.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts